X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (31) 31
index medicus (17) 17
experiment (15) 15
humans (15) 15
female (14) 14
electricity (13) 13
oncology (13) 13
high energy physics (12) 12
high energy physics - experiment (12) 12
middle aged (12) 12
nuclear experiment (12) 12
aged (11) 11
physics - high energy physics - experiment (11) 11
adult (10) 10
disease-free survival (10) 10
particle physics (10) 10
measuring (9) 9
performing operations (9) 9
testing (9) 9
transporting (9) 9
treatment outcome (9) 9
astrophysics (8) 8
generation (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
bevacizumab (7) 7
conversion or distribution of electric power (7) 7
high energy physics - phenomenology (7) 7
male (7) 7
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (6) 6
aged, 80 and over (6) 6
analysis (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
breast neoplasms - drug therapy (6) 6
chemistry (6) 6
chemotherapy (6) 6
double-blind method (6) 6
high energy astrophysical phenomena (6) 6
apparatus for conversion between ac and ac, between ac and dc,or between dc and dc, and for use with mains or similar powersupply systems (5) 5
basic electric elements (5) 5
cancer (5) 5
cancer therapies (5) 5
clinical trials (5) 5
control or regulation thereof (5) 5
conversion of dc or ac input power into surge outputpower (5) 5
drug administration schedule (5) 5
engineering (5) 5
fiber lasers (5) 5
hypertension (5) 5
kaplan-meier estimate (5) 5
metallurgy (5) 5
metastasis (5) 5
optics (5) 5
phenomenology (5) 5
physics - high energy physics - phenomenology (5) 5
physics of elementary particles and fields (5) 5
physics, particles & fields (5) 5
sunitinib (5) 5
survival (5) 5
[ phys.hphe ] physics [physics]/high energy physics - phenomenology [hep-ph] (4) 4
animals (4) 4
carcinoma, renal cell - drug therapy (4) 4
care and treatment (4) 4
collisions (4) 4
detectors (4) 4
earth drilling (4) 4
earth drilling, e.g. deep drilling (4) 4
electric switches (4) 4
elementary particles, quantum field theory (4) 4
emergency protective devices (4) 4
fixed constructions (4) 4
fysik (4) 4
hematology, oncology and palliative medicine (4) 4
interferon-alpha (4) 4
investigating or analysing materials by determining theirchemical or physical properties (4) 4
kidney neoplasms - drug therapy (4) 4
mining (4) 4
neoplasm staging (4) 4
obtaining oil, gas, water, soluble or meltable materials or aslurry of minerals from wells (4) 4
particle physics - experiment (4) 4
patients (4) 4
physical sciences (4) 4
physics and astronomy (4) 4
polymers (4) 4
pump lasers (4) 4
quality of life (4) 4
quantum field theories, string theory (4) 4
relays (4) 4
research article (4) 4
selectors (4) 4
survival analysis (4) 4
virology (4) 4
virus diseases (4) 4
viruses (4) 4
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (3) 3
antibodies (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antibodies, monoclonal, humanized - administration & dosage (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents - therapeutic use (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


04/2016
FIELD: machine building.SUBSTANCE: invention relates to machine building. Elastic element is made in form of a flexible elastic rod with fixed ends. Central... 
MECHANICAL ENGINEERING | WEAPONS | BLASTING | SHOCK-ABSORBERS | GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVEFUNCTIONING OF MACHINES OR INSTALLATIONS | MEANS FOR DAMPING VIBRATION | HEATING | SPRINGS | LIGHTING | ENGINEERING ELEMENTS AND UNITS | THERMAL INSULATION IN GENERAL
Patent
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1224 - 1235
Summary Background VEGFR-2 has a role in gastric cancer pathogenesis and progression. We assessed whether ramucirumab, a monoclonal antibody VEGFR-2... 
Hematology, Oncology and Palliative Medicine | SUPPORTIVE CARE | ONCOLOGY | BEVACIZUMAB | CLINICAL-TRIALS | GROWTH | 2ND-LINE CHEMOTHERAPY | OPEN-LABEL | 1ST-LINE THERAPY | COMBINATION | CANCER | III TRIAL | Confidence Intervals | Adenocarcinoma - pathology | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Stomach Neoplasms - pathology | Esophageal Neoplasms - pathology | Dose-Response Relationship, Drug | Esophageal Neoplasms - mortality | Adult | Female | Remission Induction - methods | Paclitaxel - administration & dosage | Double-Blind Method | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Esophagogastric Junction - pathology | Paclitaxel - adverse effects | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Adenocarcinoma - mortality | Antimitotic agents | Care and treatment | Hospitals | Clinical trials | Monoclonal antibodies | Product development | Antineoplastic agents | Vascular endothelial growth factor | Esophageal cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. 1287 - 1294
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 933 - 942
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 20, pp. 1925 - 1936
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2013, Volume 31, Issue 14, pp. 1719 - 1725
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 30, pp. 3791 - 3799
Journal Article
Optics Letters, ISSN 0146-9592, 2015, Volume 40, Issue 7, pp. 1189 - 1192
We report, for the first time to our knowledge, on a single-mode millijoule-level 100-nanosecond Er-doped fiber laser operating near 1550 nm. The system... 
POWER | AMPLIFIERS | OPTICS | EFFICIENCY | Repetition | Glass | Fibers | Fiber lasers | Optics | Physics
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 14, pp. 1678 - 1685
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2015, Volume 33, Issue 2, pp. 141 - 148
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article